Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Rinaldi

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
British Journal of Pharmacology|July 22, 2004
Indomethacin potentiates acetylcholine-induced vasodilation by increasing free radical productionAntonella De Angelis, Barbara Rinaldi, Annalisa Capuano, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 28, 2023
Pharmacokinetic considerations surrounding triple therapy for uncontrolled asthmaMaria Gabriella Matera, Barbara Rinaldi, Carmela Belardo, et al.
Pulmonary Pharmacology & Therapeutics|July 27, 2019
Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatmentMaria Gabriella Matera, Barbara Rinaldi, Luigino Calzetta, et al.
Expert Opinion on Emerging Drugs|April 22, 2020
Emerging muscarinic receptor antagonists for the treatment of asthmaMaria Gabriella Matera, Carmela Belardo, Michele Rinaldi, et al.
Expert Opinion on Pharmacotherapy|November 13, 2023
Advances in adrenergic receptors for the treatment of chronic obstructive pulmonary disease: 2023 updateMaria Gabriella Matera, Barbara Rinaldi, Luigino Calzetta, et al.
Expert Opinion on Drug Metabolism & Toxicology|January 21, 2020
A review of the pharmacokinetics of M<sub>3</sub> muscarinic receptor antagonists used for the treatment of asthmaMaria Gabriella Matera, Barbara Rinaldi, Carmela Berardo, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 29, 2018
Pharmacokinetic considerations concerning the use of bronchodilators in the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Barbara Rinaldi, Clive Page, et al.
Expert Review of Respiratory Medicine|April 23, 2020
New perspectives on the role of muscarinic antagonists in asthma therapyMaria Gabriella Matera, Carmela Belardo, Michele Rinaldi, et al.
Expert Opinion on Drug Delivery|September 16, 2023
Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseasesMaria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.
Expert Opinion on Pharmacotherapy|November 14, 2022
Current and emerging treatment modalities for bacterial rhinosinusitis in adults: a comprehensive reviewMaria Gabriella Matera, Barbara Rinaldi, Vito de Novellis, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
British Journal of Pharmacology|July 22, 2004
Indomethacin potentiates acetylcholine-induced vasodilation by increasing free radical productionAntonella De Angelis, Barbara Rinaldi, Annalisa Capuano, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 28, 2023
Pharmacokinetic considerations surrounding triple therapy for uncontrolled asthmaMaria Gabriella Matera, Barbara Rinaldi, Carmela Belardo, et al.
Pulmonary Pharmacology & Therapeutics|July 27, 2019
Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatmentMaria Gabriella Matera, Barbara Rinaldi, Luigino Calzetta, et al.
Expert Opinion on Emerging Drugs|April 22, 2020
Emerging muscarinic receptor antagonists for the treatment of asthmaMaria Gabriella Matera, Carmela Belardo, Michele Rinaldi, et al.
Expert Opinion on Pharmacotherapy|November 13, 2023
Advances in adrenergic receptors for the treatment of chronic obstructive pulmonary disease: 2023 updateMaria Gabriella Matera, Barbara Rinaldi, Luigino Calzetta, et al.
Expert Opinion on Drug Metabolism & Toxicology|January 21, 2020
A review of the pharmacokinetics of M<sub>3</sub> muscarinic receptor antagonists used for the treatment of asthmaMaria Gabriella Matera, Barbara Rinaldi, Carmela Berardo, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 29, 2018
Pharmacokinetic considerations concerning the use of bronchodilators in the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Barbara Rinaldi, Clive Page, et al.
Expert Review of Respiratory Medicine|April 23, 2020
New perspectives on the role of muscarinic antagonists in asthma therapyMaria Gabriella Matera, Carmela Belardo, Michele Rinaldi, et al.
Expert Opinion on Drug Delivery|September 16, 2023
Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseasesMaria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.
Expert Opinion on Pharmacotherapy|November 14, 2022
Current and emerging treatment modalities for bacterial rhinosinusitis in adults: a comprehensive reviewMaria Gabriella Matera, Barbara Rinaldi, Vito de Novellis, et al.
Pageof 8